Not all clients with CLL require therapy. In spite of all new innovations, the iwCLL continue to recommends watchful observation for patients with asymptomatic illness.86 This suggestion is predicated on at the very least two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab